Atlas Trials

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Clinical trial NCT03115112 · COMPLETED

Trial details

NCT number
NCT03115112
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-10-12
Primary completion
2018-10-31
Enrollment
386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.